1)大腸癌研究会(編);大腸癌取扱い規約.改訂第7版.金原出版,2006
Hamilton SR, Aaltonen LA(eds);Pathology and Genetics of Tumours of the Digestive System. Lyon, IARC Press, 2000, pp145-155
3)Sobin LH, Wittekind Ch(eds);TNM Classification of Malignant Tumors, 6th ed. New York, Wiley-Liss, 2002, pp77-80
4)Robert VP:AJCC Cancer Staging Manual, 6th ed. New York, Springer, 2002, pp125-130
5)鮫島伸一,澤田俊夫,長廻 鉱:本邦における肛門扁平上皮癌,痔瘻癌の現況,第59回大腸癌研究会アンケート調査報告.日本大腸肛門病会誌 58:415-421,2005
6)斎田俊明:悪性黒色腫.玉置邦彦,飯塚 一,清水 宏,他(編);最新皮膚科学体系11.中山書店,2002,pp226-246
7)大腸癌研究会(編);大腸癌治療ガイドライン 医師用.2005年版.金原出版,2005
8)Swedish Rectal Cancer Group:Improved survival with preoperative radiotherapy in respectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336:980-987, 1997
9)Hojo K, Koyama Y:The effectiveness of wide anatomical resection and radical lymphadenectomy for patients with rectal cancer. Jpn J Surg 12:111-116, 1982
10)佐藤美信,丸田守人,前田耕太郎,他:直腸癌に対する側方リンパ節郭清を伴う自律神経温存手術の適応に関する検討.日本大腸肛門病会誌 53:1-11,2000
11)Maeda K, Maruta M, Utsumi T, et al:Bladder and male sexual functions after autonomic nerve-sparing TME with or without lateral node dissection for rectal cancer. Tech Coloproctol 7:29-33, 2003
12)Sato H, Maeda K, Maruta M, et al:Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection? Dis Colon Rectum 49:S3-S12, 2006
13)高橋 孝,古島 薫,太田博俊,他:肛門癌のリンパ節転移の特徴―とくに鼠径リンパ節転移について.日本大腸肛門病会誌 34:473-478,1981
14)林 賢,廣田映五,板橋正幸,他:肛門管癌の臨床病理学的検討.日消外会誌 22:2414-2420,1989
15)Rosser C:The etiology of anal cancer. Am J Surg 11:328-333, 1931
16)Skir I:Mucinous carcinoma associated with fistula of long-standing. Am J Surg 75:285-289, 1948
17)隅越幸男,岡田光生,岩垂純一,他:痔瘻癌.日本大腸肛門病会誌 34:467-472,1981
18)岩垂純一:長期の痔瘻の既往を有する肛門管癌,いわゆる痔瘻癌の臨床病理学的研究.日本大腸肛門病会誌 44:461-476,1991
19)山名哲郎,牧田幸三,岩垂純一:MRIによる骨盤直腸窩痔瘻の診断.日本大腸肛門病会誌 55:799-806,2002
20)Sato H, Maeda K, Maruta M, et al:Mucinous adenocarcinoma associated with chronic anal fistula reconstructed by gracilis myocutaneous flaps. Tech Coloproctol 10:249-252, 2006
21)Sato H, Koh PK, Bartolo DC:Management of anal canal cancer. Dis Colon Rectum 48:1301-1315, 2005
22)Nigro ND, Vaitkeviius VK, Considine B Jr:Combined therapy for cancer of anal canal:A preliminary report. Dis Colon Rectum 17:354-356, 1974
23)Bartelink H, Roelofsen F, Eschwege F, et al:Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer:results of phase Ⅲ randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997
24)UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Comittee on Cancer Research:Epidermoid anal cancer:results from the UKCCCR randomized trial of radiography alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049-1054, 1996
25)Cummings BJ, Keane TJ, O'Sullivan B, et al:Epidermoid anal cancer:treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115-1125, 1991
26)Falm M, John M, Pajak TF, et al:Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal:results of a phase 3 randomized intergroup study. J Clin Oncol 14:2527-2539, 1996
27)Doci R, Zucali R, La Monica G, et al:Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus:results in 35 consecutive patients. J Clin Oncol 14:3121-3125, 1996
28)Peiffert D, Seitz JF, Rougier P, et al:Preliminary effects of a phase Ⅱ study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer. A French cooperative study. Ann Oncol 8:575-581, 1997
29)Ajani JA, Winter KA, Gunderson LL, et al:Intergroup RTOG 98-11:A phase Ⅲ randomized study of 5-fluorouracil(5-FU), mitomicin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 2006 ASCO Annual Meeting Proceedings Part Ⅰ 24:18S, 2006
30)NCCN. http://www.nccn.org